Domestic drug regulator plans to inspect firms abroad, like USFDA

So far, CDSCO has only conducted risk-based assessment of manufacturing units in India

The Central Drugs Standard Control Organisation (CDSCO) is chalking out an international road map, while wanting to follow in the footsteps of its American counterpart. The goal of the CDSCO is to inspect  pharma companies and their manufacturing units in other countries, especially the US, across Europe, Japan and China. ‘’The national drug regulator would conduct risk-based assessments of companies which supply to India,’’ an official at the CDSCO told Business Standard. 

So far, the Indian drug controller has only conducted risk-based assessments of manufacturing units in India. Once it starts inspecting manufacturing units overseas, the Indian regulator’s role would